|
Market Closed -
Nasdaq
01:30:00 19/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 8.030 USD | +2.16% |
|
-4.74% | +11.37% |
| Market Cap | 24Cr 21Cr 20Cr 18Cr 33Cr 2.28TCr 33Cr 233.74Cr 90Cr 1.16TCr 89Cr 87Cr 3.73TCr | P/E 2026 * |
-2.68x | P/E 2027 * | -1.93x |
|---|---|---|---|---|---|
| Enterprise Value | 9.68Cr 8.43Cr 7.96Cr 7.23Cr 14Cr 928.02Cr 14Cr 95Cr 37Cr 472.03Cr 36Cr 36Cr 1.52TCr | EV / Sales 2026 * |
231x | EV / Sales 2027 * | -182x |
| Free-Float |
47.87% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| RNAC | Delayed | |
CBOE
| RNAC | Real-time | |
|
Deutsche Boerse AG
| 1S70 | Delayed | |
|
Boerse Muenchen
| 1S70 | Real-time |
Last Transcript: Cartesian Therapeutics, Inc.
| 1 day | +2.16% | ||
| 1 week | -4.74% | ||
| Current month | -13.47% | ||
| 1 month | -12.53% | ||
| 3 months | -18.72% | ||
| 6 months | +11.84% | ||
| Current year | +11.37% |
| 1 week | 7.66 |  | 8.27 |
| 1 month | 7.66 | | 10.88 |
| Current year | 5.6 | | 11 |
| 1 year | 5.6 | | 11 |
| 3 years | 5.6 | | 42.6 |
| 5 years | 5.6 | | 42.6 |
| 10 years | 5.6 | | 42.6 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 02/04/26 | Exercice | 7,58,001 | 2.8594% | |||
| 02/04/26 | Exercice | 22,740 | - | - | ||
| 02/04/26 | Exercice | 22,740 | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.16% | -4.74% | -12.24% | - | 24Cr | |
| -0.31% | +3.56% | +46.40% | +100.50% | 7.09TCr | |
| +0.39% | +1.82% | +38.93% | +77.73% | 6.23TCr | |
| -3.21% | -5.72% | -17.12% | +350.96% | 2.71TCr | |
| -2.64% | -0.35% | -2.13% | -15.04% | 2.48TCr | |
| +0.71% | +8.50% | +27.76% | -15.29% | 2.06TCr | |
| -1.26% | -10.61% | +170.72% | +290.48% | 1.55TCr | |
| -0.22% | +1.62% | +44.31% | +167.58% | 1.45TCr | |
| +0.73% | +5.00% | -1.33% | +854.55% | 1.41TCr | |
| -0.54% | -0.30% | +27.33% | +202.19% | 1.23TCr | |
| Average | -0.31% | +0.84% | +32.26% | +223.74% | 2.62TCr | |
| Weighted average by Cap. | -0.53% | +1.38% | +35.74% | +161.34% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4L 4L 3L 3L 6L 4.02Cr 6L 41.2L 15.91L 2.04Cr 15.74L 15.39L 6.57Cr | 3L 2L 2L 2L 4L 2.74Cr 4L 28.08L 10.85L 1.39Cr 10.73L 10.49L 4.48Cr |
| Net income | -8.81Cr -7.67Cr -7.24Cr -6.58Cr -12Cr -844.75Cr -12Cr -87Cr -33Cr -429.67Cr -33Cr -32Cr -1.38TCr | -14Cr -13Cr -12Cr -11Cr -20Cr -1.38TCr -20Cr -141.56Cr -55Cr -702.25Cr -54Cr -53Cr -2.26TCr |
| Net Debt | -14Cr -12Cr -12Cr -11Cr -20Cr -1.35TCr -20Cr -138.59Cr -54Cr -687.52Cr -53Cr -52Cr -2.21TCr | -29Cr -25Cr -24Cr -22Cr -41Cr -2.78TCr -41Cr -284.74Cr -109.98Cr -1.41TCr -108.82Cr -106.4Cr -4.54TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/26/18 | $8.030 | +2.16% | 2,11,360 |
| 17/26/17 | $7.860 | -0.63% | 1,64,460 |
| 16/26/16 | $7.910 | +0.25% | 1,17,997 |
| 15/26/15 | $7.890 | -1.87% | 1,13,269 |
| 14/26/14 | $8.040 | -1.83% | 1,10,247 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- RNAC Stock
Select your edition
All financial news and data tailored to specific country editions
